CRO Services Center (Phase I-III)

Clinical Trials are required for drug therapies to receive regulatory approval.

A Phase 1 trial is the first to involve human subjects, and its objective is to determine the highest dose of a treatment that can be safely administered to patients. A Phase 2 trial is conducted on a small number of patients to determine if the drug is effective. If the Phase 1 and Phase 2 trials are successful, a larger Phase 3 trial is conducted to gather data to present to the FDA. In a Phase 3 trial a drug is often tested against a placebo or the current standard of care. Clinical trials are expensive and time consuming, and they require expertise in many areas. Sponsors need to perform study startup (which includes site selection and patient recruitment), manage and oversee the trial, and collect and analyze trial data. All of these operations can be performed by a CRO.

How can we help?

Looking for help with your Phase I-III project? If you're searching for information or a supplier, let Clinical Leader lend you a hand.

Submit A Question

CRO Services Center (Phase I-III) Provider - Advarra
Advarra

Advarra optimizes compliance and clinical trials as the premier provider of global research compliance services, including IRB, IBC, consulting, and research technology products. Clinical trial sponsors and CROs recognize Advarra as the largest integrated provider of IRB services with the greatest institutional reach among health systems, cancer centers, academic medical centers, and investigators.

Capabilities

CRO Services Center (Phase I-III) Provider - Biorasi
Biorasi

Biorasi is an award-winning contract research organization accelerating drug and device clinical development for life sciences companies around the world. Since 2002, Biorasi has achieved success in bringing innovative therapies to market for our sponsors. Biorasi solves the problem of poor clinical trial performance with better patient recruitment, powerful data insights, and operational excellence.

Capabilities

CRO Services Center (Phase I-III) Provider - Catalyst Clinical Research
Catalyst Clinical Research

Catalyst Clinical Research is a clinical development organization providing highly customizable solutions to the global biopharmaceutical industry. Built from more than two decades of listening to their customers, devising customer-centric solutions and helping them breakthrough with clinical development programs surrounded by therapeutically aligned teams of experts.

Capabilities


Have questions about selecting the right Phase I-III service provider?

The Clinical Leader team can help. We'll match your needs with the right companies.

Contact us via email for assistance.

CRO Services Center (Phase I-III) Provider - Cytel
Cytel

Now more than ever, the clinical development path is full of make-or-break data complexities and analytical challenges. As a pioneer in evidence generation, with deep expertise in advanced analytical solutions, we are uniquely equipped to unlock the value from increasingly complex data. Life Sciences companies count on Cytel to deliver exceptional insight, minimize trial risk and accelerate the development of promising new medicines that improve human life.

Capabilities

CRO Services Center (Phase I-III) Provider - PAREXEL
Parexel

Parexel is in the business of improving the world’s health. We do this by providing a suite of biopharmaceutical services that help clients across the globe transform scientific discoveries into new treatments. From clinical trials to regulatory, consulting, and market access, our therapeutic, technical, and functional ability is underpinned by a deep conviction in what we do.

CRO Services Center (Phase I-III) Provider - Premier Research
Premier Research

Premier Research recognizes that when an emerging biotech is built around a single asset, focus and flexibility are critical to success. And, since many of our customers require additional infrastructure, we fill in resourcing gaps to help their product reach the patient faster. We are a mid-size CRO and offer strategies that are customized for each program, with tailored processes designed to meet highly specific needs.


CRO Services Center (Phase I-III) Provider - Rho
Rho

Rho is a privately-held contract research organization (CRO) located in Chapel Hill, NC. We provide a full range of clinical research services across the entire drug development process. For 30 years, we’ve been a trusted partner to some of the industry’s leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations.

Capabilities

CRO Services Center (Phase I-III) Provider - TrialScope
TrialScope

TrialScope is the global leader in clinical trial disclosure and transparency management technology, supporting 13 of the top 15 industry clinical trial sponsors worldwide. TrialScope provides proven solutions that are designed to optimize the efficiency of disclosure activities, maximize trial data transparency, and foster more informed, engaged patients through open research sharing.

CRO Services Center (Phase I-III) Provider - United BioSource - UBC
United BioSource - UBC

United BioSource LLC (UBC) is a leading provider of pharmaceutical support services, partnering with life science companies to make medicine and medical products safer and more accessible. UBC is well known for our expertise in generating authoritative, real-world evidence of product effectiveness, safety, and value to assist healthcare decisions and enhance patient care.

Capabilities